PT  - JOURNAL ARTICLE
AU  - Oh, Chiwoo
AU  - Bishop, Michael W.
AU  - Cho, Steve Y.
AU  - Im, Hyung-Jun
AU  - Shulkin, Barry L.
TI  - <sup>18</sup>F-FDG PET/CT in the Management of Osteosarcoma
AID  - 10.2967/jnumed.123.265592
DP  - 2023 Jun 01
TA  - Journal of Nuclear Medicine
PG  - 842--851
VI  - 64
IP  - 6
4099  - http://jnm.snmjournals.org/content/64/6/842.short
4100  - http://jnm.snmjournals.org/content/64/6/842.full
SO  - J Nucl Med2023 Jun 01; 64
AB  - Osteosarcoma is the most common type of primary malignant bone tumor. 18F-FDG PET/CT is useful for staging, detecting recurrence, monitoring response to neoadjuvant chemotherapy, and predicting prognosis. Here, we review the clinical aspects of osteosarcoma management and assess the role of 18F-FDG PET/CT, in particular with regard to pediatric and young adult patients.